Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis
2024
Alarcan H et Al.
Annals of the New York Academy of Sciences, 10.1111/nyas.15147.
2024
Alarcan H et Al.
Annals of the New York Academy of Sciences, 10.1111/nyas.15147.